News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Young David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2023 |
4
| Young David (President & CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Bought 40,000 shares
@ $0.8, valued at
$32k
|
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Young David (President & CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 25,350 restricted stock units
@ $0
Granted 24,030 restricted stock units
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Young David (President & CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Exercised 7,601 shares
@ $0
Paid exercise price by delivering 2,531 shares
@ $3.17, valued at
$8k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2022 |
4
| Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 247,841 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 4,286 restricted stock units
@ $0
Granted 10,715 restricted stock units
@ $0 |
|
| 01/06/2022 |
4/A
| Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 6,722 restricted stock units
@ $0 |
|
| 01/06/2022 |
4/A
| Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 6,024 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 6,722 restricted stock units
@ $0 |
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| Young David (CEO) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 8,572 restricted stock units
@ $0
Granted 12,858 restricted stock units
@ $0
Granted 1,907 restricted stock units
@ $0 |
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
SC 13D
| Young David reports a 14.2% stake in PROCESSA PHARMACEUTICALS, INC. |
| 10/05/2020 |
3/A
| Young David (CEO) has filed a Form 3/A on Processa Pharmaceuticals, Inc. |
| 10/02/2020 |
3
| Young David (CEO) has filed a Form 3 on Processa Pharmaceuticals, Inc. |
| 08/18/2014 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Disposed/sold 70,991 shares
@ $0
Disposed/sold 32,750 shares
@ $0
Disposed/sold 14,000 shares
@ $0
Disposed/sold 1,500 options to buy
@ $5.77, valued at
$8.7k
Disposed/sold 22,500 options to buy
@ $9.31, valued at
$209.5k
Disposed/sold 71,000 options to buy
@ $4.54, valued at
$322.3k
Disposed/sold 85,416 options to buy
@ $14.24, valued at
$1.2M
Disposed/sold 74,375 options to buy
@ $35.78, valued at
$2.7M
|
|
| 06/26/2014 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 6,000 shares
@ $91.9606, valued at
$551.8k
Exercised 6,000 options to buy
@ $4.54, valued at
$27.2k
|
|
| 03/18/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2014 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Exercised 6,000 options to buy
@ $5.77, valued at
$34.6k
|
|
| 02/26/2014 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Granted 14,000 shares
@ $0
Disposed/sold 16,667 shares
@ $0
Paid exercise price by delivering 17,127 shares
@ $79.46, valued at
$1.4M
Sold 6,000 shares
@ $78.8816, valued at
$473.3k
Exercised 6,000 options to buy
@ $4.54, valued at
$27.2k
|
|
| 01/31/2014 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Exercised 10,000 options to buy
@ $5.77, valued at
$57.7k
Exercised 10,000 options to buy
@ $9.31, valued at
$93.1k
|
|
| 01/28/2014 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 6,000 shares
@ $64.3824, valued at
$386.3k
Exercised 6,000 options to buy
@ $4.54, valued at
$27.2k
|
|
| 11/21/2013 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Exercised 15,000 options to buy
@ $5.77, valued at
$86.6k
|
|
| 11/15/2013 |
4
| Young David (Chief Scientific Officer) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 100,000 shares
@ $62.4003, valued at
$6.2M
Exercised 100,000 options to buy
@ $4.54, valued at
$454k
|
|
| 04/12/2013 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
|
|
|